Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Eton

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Leukemia|October 1, 1989
Establishment and characterization of two human myeloma cell lines secreting kappa light chainsO Eton, D A Scheinberg, A N Houghton
The New England Journal of Medicine|January 30, 1992
Cutaneous melanomaO Eton, S S Legha, C M Balch
Investigational New Drugs|February 1, 1991
Phase II trial of N-methylformamide in patients with metastatic melanomaO Eton, D F Bajorin, E S Casper, et al.
The Cancer Journal From Scientific American|February 11, 1998
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experienceS S Legha, S Ring, O Eton, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of cisplatin and etoposide in patients with metastatic melanomaO Eton, D F Bajorin, P B Chapman, et al.
Oncology Reports|July 30, 1999
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapyJ A Ellerhorst, A Bedikian, S Ring, et al.
Cancer|March 1, 1996
Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanomaO Eton, M Talpaz, K H Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanomaS S Legha, S Ring, O Eton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alphaS S Legha, S Ring, A Bedikian, et al.
Hormone Research|June 12, 1998
Hypercalcemia due to parathyroid hormone-related protein secretion by melanomaS C Yeung, O Eton, D W Burton, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Leukemia|October 1, 1989
Establishment and characterization of two human myeloma cell lines secreting kappa light chainsO Eton, D A Scheinberg, A N Houghton
The New England Journal of Medicine|January 30, 1992
Cutaneous melanomaO Eton, S S Legha, C M Balch
Investigational New Drugs|February 1, 1991
Phase II trial of N-methylformamide in patients with metastatic melanomaO Eton, D F Bajorin, E S Casper, et al.
The Cancer Journal From Scientific American|February 11, 1998
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experienceS S Legha, S Ring, O Eton, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of cisplatin and etoposide in patients with metastatic melanomaO Eton, D F Bajorin, P B Chapman, et al.
Oncology Reports|July 30, 1999
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapyJ A Ellerhorst, A Bedikian, S Ring, et al.
Cancer|March 1, 1996
Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanomaO Eton, M Talpaz, K H Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanomaS S Legha, S Ring, O Eton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alphaS S Legha, S Ring, A Bedikian, et al.
Hormone Research|June 12, 1998
Hypercalcemia due to parathyroid hormone-related protein secretion by melanomaS C Yeung, O Eton, D W Burton, et al.
Pageof 4